Regocent

Regocent 40mg (Regorafenib): Complete Guide to Uses, Dosage, Benefits, Side Effects & FAQs

Regocent 40mg, containing the active generic ingredient Regorafenib, belongs to our Prescription Medicines, Oncology & Cancer Medicines, and Anticancer Medicines categories. This medication is a multi-kinase inhibitor designed to target and slow the progression of specific types of cancer cells.

Introduction to Regocent 40mg

Regocent 40mg is a potent prescription medicine used to treat advanced stages of colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer). Instead of acting like traditional chemotherapy, Regocent 40mg works at the molecular level to block the signals that allow cancer cells to grow and multiply. Think of Regorafenib as a precision-targeted therapy that cuts off the blood supply to tumors while simultaneously inhibiting the survival pathways of malignant cells.

Drug Class and Mechanism of Action

Regocent 40mg is classified as an oral multi-kinase inhibitor. The active generic, Regorafenib, works by blocking several enzymes (kinases) located on the surface of and within cancer cells. Specifically, it inhibits kinases involved in “angiogenesis” (the growth of new blood vessels that feed tumors), “oncogenesis” (the process by which healthy cells become cancerous), and the maintenance of the tumor microenvironment. By targeting these multiple pathways, Regorafenib provides a comprehensive attack against tumor progression.

How Regocent 40mg Works in the Body

Cancer cells rely on complex signaling networks to thrive and spread. Regocent 40mg interrupts these specific signaling pathways to help:

• Stop the formation of new blood vessels that provide oxygen and nutrients to tumors.

• Block the signals that tell cancer cells to divide and grow.

• Inhibit the proteins that help cancer cells survive and resist the body’s natural immune responses.

• Limit the ability of the cancer to spread to other parts of the body (metastasis).

Medical Uses of Regocent 40mg

Regocent 40mg is approved for patients who have previously been treated with other anticancer therapies.

For Colorectal Cancer: Regocent 40mg is used for patients with metastatic colorectal cancer who have already received standard chemotherapy and other targeted treatments. It helps extend survival by slowing down the growth of the disease.

For Liver Cancer (Hepatocellular Carcinoma): As a powerful form of Regorafenib, it is prescribed for patients with liver cancer who have been previously treated with sorafenib. It provides a vital second-line treatment option to manage the condition.

For Gastrointestinal Stromal Tumors (GIST): It is used for patients with advanced GIST that can no longer be treated with surgery or whose disease has progressed despite other treatments.

Who Can Take Regocent 40mg?

A specialized oncology evaluation is mandatory before starting Regocent 40mg.

• Eligibility: Adults with specific advanced cancers whose disease has progressed after previous treatments.

• Who Should Avoid: Individuals with severe liver impairment, those with unhealed wounds or recent major surgery, and women who are pregnant or breastfeeding.

Regocent 40mg Dosage and Administration

Strict adherence to the prescribed cycle of Regocent 40mg is essential:

• Standard Dose: The typical dose is 160mg (four Regocent 40mg tablets) taken once daily for the first 21 days of a 28-day cycle.

• Food Requirements: Take Regocent 40mg at the same time each day after a low-fat meal (containing less than 600 calories and less than 30% fat).

• Administration: Swallow the tablets whole with water. Do not crush or chew the medication.

• Cycle Management: Always follow the “3 weeks on, 1 week off” schedule as directed by your oncologist.

Benefits of Regocent 40mg

Key advantages of choosing Regocent 40mg include:

• Multi-Targeted Approach: Attacks cancer from multiple angles (blood supply and cell growth).

• Oral Convenience: A tablet formulation that allows for treatment at home rather than requiring intravenous hospital visits.

• Proven Efficacy: Clinically shown to improve progression-free survival in patients with limited treatment options.

• Precision Therapy: Specifically designed for patients whose tumors have become resistant to other therapies.

Side Effects of Regocent 40mg

As a potent anticancer agent, Regocent 40mg can cause side effects.

• Common Effects: Fatigue, loss of appetite, hand-foot skin reaction (redness/swelling of palms/soles), diarrhea, and high blood pressure.

• Less Common: Voice changes (hoarseness), nausea, and weight loss.

• Serious Risks: Severe liver toxicity, heavy bleeding, and gastrointestinal perforation.

• Note: Inform your medical team immediately if you notice yellowing of the skin or eyes (jaundice) or severe abdominal pain.

Warnings and Precautions

Before starting Regocent 40mg, please consider:

• Liver Function: Regular blood tests are required to monitor liver health, especially during the first two months of Regorafenib therapy.

• Blood Pressure: Blood pressure should be monitored weekly for the first six weeks of treatment.

• Wound Healing: Regocent 40mg can affect healing; treatment should be stopped at least 2 weeks before a scheduled surgery.

• Contraception: Both men and women should use effective birth control during treatment and for at least 2 months after the final dose of Regorafenib.

Frequently Asked Questions (FAQs)

1. Why must I take Regocent 40mg with a low-fat meal? A high-fat meal can change how the body absorbs Regorafenib, potentially increasing the risk of side effects. A low-fat meal ensures the medicine is absorbed correctly.

2. What is “hand-foot skin reaction”? This is a common side effect of Regocent 40mg where the skin on the palms and soles becomes red, painful, or blistered. Your doctor may suggest creams or dose adjustments to manage this.

3. Is Regocent 40mg considered chemotherapy? While it is an anticancer medicine, it is specifically a “targeted therapy” (kinase inhibitor), which works differently than traditional cytotoxic chemotherapy.

Conclusion & Medical Disclaimer

Regocent 40mg (Regorafenib) offers a significant therapeutic option for patients fighting advanced cancers, providing hope through its multi-targeted mechanism. This content is for informational purposes only and does not replace professional medical advice. Always consult a qualified oncologist before starting or changing any cancer treatment.